Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9795646 | 0.85 | KDM4E (0.51) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL29360687 | 0.85 | KDM4E (0.51) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL22444376 | 0.83 | KDM4E (0.50) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL19675068 | 0.82 | RAB9A (0.50) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL457928 | 0.81 | RAB9A (0.49) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL19628225 | 0.81 | RAB9A (0.49) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL10023111 | 0.80 | RAB9A (0.47) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL12944860 | 0.78 | RAB9A (0.44) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL13350159 | 0.77 | RAB9A (0.46) | RAB9AKDM4EALDH1A1HPGDMAPT | |
| SCHEMBL15856913 | 0.77 | KDM4E (0.43) | RAB9AKDM4EALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017074052-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2017-05-04 | — | — | WO | disclosed |
| WO-2017074053-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2017-05-04 | — | — | WO | disclosed |
| US-8384074-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-02-26 | — | — | US | disclosed |
| US-8384074-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-02-26 | — | — | US | disclosed |
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD (KR) | 2011-10-06 | — | — | US | disclosed |
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD (KR) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LEF1, IDO1, NOD1 | RAB9A 3693/4885KDM4E 2764/4885ALDH1A1 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.